EventPilot Web App

Enter Note Done

Go to previous page in this tab

Session

Paper Session
Retinitis pigmentosa

Schedule

Notes

Credits

612 - Seattle Convention Center - Arch Building

236

Set Timezone

Timezone

Location: 612 - Seattle Convention Center - Arch Building

Moderators:
Jacque L Duncan, (Univ of California - SF)
Rachel M Huckfeldt, (Massachusetts Eye and Ear)

Session Types

Section

Download Abstracts as PDF

Presentations

Presentation

Paper Session

CDHR1-associated retinal degeneration: clinical phenotypes, natural history and molecular genetics from 135 cases

3:00pm-3:15pm May 6 (Pacific)

612 - Seattle Convention Center - Arch Building

Presentation

Paper Session

Subretinal gene therapy AGTC-501 for X-linked retinitis pigmentosa in the Phase 1/2 Horizon study: Post-hoc analysis of microperimetry results in the high dose groups

3:15pm-3:30pm May 6 (Pacific)

612 - Seattle Convention Center - Arch Building

Presentation

Paper Session

12-Month Safety and Efficacy Evaluation of HORA-PDE6B, a Gene Therapy Targeting Patients with Retinitis Pigmentosa Due to Biallelic PDE6B Gene Mutation.

3:30pm-3:45pm May 6 (Pacific)

612 - Seattle Convention Center - Arch Building

Presentation

Paper Session

Sub-retinal gene therapy improves function and structure in patients with Bothnia Dystrophy

3:45pm-4:00pm May 6 (Pacific)

612 - Seattle Convention Center - Arch Building

Presentation

Paper Session

Multicentric longitudinal prospective study in Usher Syndrome due to MYO7A mutations: disease course and implications for gene therapy

4:00pm-4:15pm May 6 (Pacific)

612 - Seattle Convention Center - Arch Building

Presentation

Paper Session

Longitudinal BCVA analysis of low- or high-dose MCO-010 mutation agnostic optogenetic therapy for retinitis pigmentosa: 12-month results from a Phase 2b/3 randomized, sham-controlled, patient- and assessor-masked clinical trial (RESTORE)

4:15pm-4:30pm May 6 (Pacific)

612 - Seattle Convention Center - Arch Building

Presentation

Paper Session

Static Perimetry-OCT Topographical Overlay Findings in the RUSH2A Study

4:30pm-4:45pm May 6 (Pacific)

612 - Seattle Convention Center - Arch Building

Discussion